Ligand Pharmaceuticals
LGND
LGND
203 hedge funds and large institutions have $1.12B invested in Ligand Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 78 increasing their positions, 67 reducing their positions, and 33 closing their positions.
Holders
203
Holders Change
-8
Holders Change %
-3.79%
% of All Funds
3.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
78
Reduced
67
Closed
33
Calls
$3.97M
Puts
$2.61M
Net Calls
+$1.36M
Net Calls Change
-$2.29M
Top Buyers
| 1 |
1
Man Group
London,
United Kingdom
|
$10.5M |
| 2 |
2
Aberdeen Group
Edinburgh,
United Kingdom
|
$28M |
| 3 |
3
Janus Henderson Group
London,
United Kingdom
|
$96.9M |
| 4 |
4
BlackRock
New York
|
$210M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$38.3M |
